Evaluate extent of cervical cancer involvement of adjacent structures, as well as lymphadenopathy. Postmenopausal bleeding. PELVIS:UTERUS, ADNEXA: There is a heterogeneously enhancing mass arising from the right cervix compatible with known cervical carcinoma, measuring approximately 3.2 x 2.0 cm axially (series 801, image 29) by 2.1 cm in sagittal dimension (series 701, image 25). The mass is slightly decreased in size from the prior CT. There is invasion into the right parametrium. The lesion abuts the bladder and rectum though there is no definite evidence of invasion. There is a mildly distended endometrial complex, which is decreased from prior exam.A small T2 hyperintense tubular structure in the right adnexa may represent mild hydrosalpinx (series 801, image 37); correlation with ultrasound may be considered. The uterus contains multiple fibroids, primarily submucosal and intramural.BLADDER: No significant abnormality noted.LYMPH NODES: Multiple small pelvic lymph nodes are redemonstrated. These were noted to be mildly hypermetabolic on prior PET, but are not enlarged by size criteria. The previously measured right pelvic sidewall lymph node currently measures 1.6 x 0.6 cm (series 1301, image 336).BOWEL, MESENTERY: No significant abnormality noted.BONES, SOFT TISSUES: No significant abnormality noted.OTHER: No significant abnormality noted.
1.Mass in the right aspect of the cervix is compatible with known cervical carcinoma, right-sided parametrial invasion present. Accounting for differences in technique/modality, mass is slightly decreased in size from prior CT. Also seen is improvement in degree of dilatation of endometrial complex. 2.No lymphadenopathy by size criteria.3.Tubular structure in the right adnexa may represent mild hydrosalpinx.